2:1 atrioventricular block during atrioventricular node reentrant tachycardia

J Am Coll Cardiol. 1996 Dec;28(7):1770-4. doi: 10.1016/S0735-1097(96)00415-9.

Abstract

Objectives: The purpose of this study was to determine the incidence and to clarify the mechanism of 2:1 atrioventricular (AV) block during AV node reentrant tachycardia induced in the electrophysiology laboratory.

Background: In patients with 2:1 AV block during AV node reentrant tachycardia, the absence of a His bundle potential in the blocked beats has been considered evidence of intranodal, lower common pathway block.

Methods: In consecutive patients with AV node reentrant tachycardia, the incidence of 2:1 AV block and the response to atropine and a single ventricular extrastimulus was observed.

Results: Persistent 2:1 AV block occurred in 13 of 139 patients with AV node reentrant tachycardia. A His bundle deflection was present in the blocked beats in eight patients and absent in five. Patients with 2:1 AV block had a shorter tachycardia cycle length than did patients without such block (mean +/- SD 312 +/- 32 vs. 353 +/- 55 ms, p < 0.01). Atropine did not alter the 2:1 block in any patient. In every patient, a single ventricular extrastimulus introduced during the tachycardia converted the 2:1 block to 1:1 conduction.

Conclusions: The incidence of induced 2:1 AV block during AV node reentrant tachycardia is approximately 10%. The lack of a response to atropine and the consistent conversion of 2:1 block to 1:1 conduction by a ventricular extrastimulus indicate that, regardless of the presence or absence of a His bundle potential in blocked beats, 2:1 block during AV node reentrant tachycardia is due to functional infranodal block.

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / pharmacology
  • Atropine / pharmacology
  • Bundle of His / physiopathology
  • Cardiac Pacing, Artificial
  • Electrocardiography
  • Female
  • Heart Block / etiology*
  • Heart Block / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Tachycardia, Atrioventricular Nodal Reentry / complications*
  • Tachycardia, Atrioventricular Nodal Reentry / physiopathology

Substances

  • Anti-Arrhythmia Agents
  • Atropine